Stay updated on Safety Tolerance Efficacy in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.

Latest updates to the Safety Tolerance Efficacy in IPF Clinical Trial page
- Check3 days agoChange DetectedAdded a resource section linking to additional information about Idiopathic Pulmonary Fibrosis, including the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a version-control update with no visible content changes to the page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page removes the 'Interstitial lung disease 2' item and the 'Genetic and Rare Diseases Information Center' resource. This could affect navigation and access to related information.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is a metadata version update and does not alter study data, eligibility criteria, locations, or results.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed. This update appears to be a backend version change with no visible changes to the study details.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 was added to the page history. The notice about a lapse in government funding and the previous Revision: v3.4.1 entry were removed.SummaryDifference0.4%

Stay in the know with updates to Safety Tolerance Efficacy in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.